diabetes mellitus, type 2
Showing NaN - NaN of 183
Diabetes, Diabetes, Type 1, Diabetes, Type 2 Trial in Worldwide (insulin aspart, inhaled human insulin)
Terminated
- Diabetes
- +3 more
- insulin aspart
- inhaled human insulin
-
Fresno, California
- +31 more
Sep 3, 2018
Diabetes, Type 2, Hypertension Trial in United States (Empagliflozin low dose, , Empagliflozin high dose)
Completed
- Diabetes Mellitus, Type 2
- Hypertension
- Empagliflozin low dose
- +2 more
-
Birmingham, Alabama
- +91 more
Jul 4, 2018
Diabetes, Type 2 Trial in Worldwide (, linagliptin)
Diabetes, Type 2 Trial in United States (Exenatide once weekly suspension, Exenatide twice daily)
Completed
- Diabetes Mellitus, Type 2
- Exenatide once weekly suspension
- Exenatide twice daily
-
Muscle Shoals, Alabama
- +57 more
Jun 4, 2018
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/insulin aspart, insulin degludec, insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec/insulin aspart
- +2 more
-
Greenbrae, California
- +50 more
Mar 6, 2018
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin glargine, insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec/liraglutide
- +2 more
-
Tuscumbia, Alabama
- +116 more
Mar 1, 2018
Diabetes, Type 2 Trial in Canada (rosiglitazone/metformin)
Completed
- Diabetes Mellitus, Type 2
-
Calgary, Alberta, Canada
- +90 more
Mar 19, 2018
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin degludec, liraglutide)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec/liraglutide
- +2 more
-
Birmingham, Alabama
- +301 more
Feb 16, 2018
Type 2 Diabetes, Diabetes, Type 2 Trial in United States (Biphasic Remogliflozin Etabonate, Placebo)
Completed
- Type 2 Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Biphasic Remogliflozin Etabonate
- Placebo
-
Tucson, Arizona
- +18 more
Jan 16, 2018
Diabetes, Type 2 Trial in Worldwide (GSK189075, Placebo)
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, , liraglutide)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec
- +2 more
-
Anaheim, California
- +131 more
Aug 25, 2017
Diabetes, Type 2 Trial in Worldwide (Canagliflozin 100 mg, Canagliflozin 300 mg, Metformin XR)
Completed
- Diabetes Mellitus, Type 2
- Canagliflozin 100 mg
- +2 more
-
Birmingham, Alabama
- +136 more
Jun 12, 2017
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec/liraglutide
-
Hamilton, Alabama
- +83 more
Apr 24, 2017
Diabetes, Type 2 Trial in Worldwide (pioglitazone, rosiglitazone, )
Terminated
- Diabetes Mellitus, Type 2
- pioglitazone
- +4 more
-
Long Beach, California
- +330 more
Mar 21, 2017
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, insulin glargine, insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec
- +2 more
-
Alexander City, Alabama
- +135 more
Mar 8, 2017
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec/insulin aspart
-
Concord, California
- +41 more
Feb 9, 2017
Diabetes, Diabetes, Type 2 Trial in Puerto Rico, United States (insulin detemir)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin detemir
-
Goodyear, Arizona
- +68 more
Jan 30, 2017
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin detemir, insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin detemir
- insulin aspart
-
Fresno, California
- +68 more
Jan 30, 2017
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin detemir, insulin glargine)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin detemir
- insulin glargine
-
Litchfield Park, Arizona
- +87 more
Jan 30, 2017
Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, exenatide)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
-
Birmingham, Alabama
- +125 more
Jan 25, 2017
Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, sitagliptin, metformin)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- liraglutide
- +2 more
-
Birmingham, Alabama
- +165 more
Jan 25, 2017
Diabetes, Diabetes, Type 2 Trial in Mexico, Puerto Rico, United States (liraglutide, glimepiride, )
Terminated
- Diabetes
- Diabetes Mellitus, Type 2
- liraglutide
- +2 more
-
Concord, California
- +116 more
Jan 24, 2017
Diabetes, Type 2 Trial in Worldwide (Placebo, Linagliptin 5mg)
Completed
- Diabetes Mellitus, Type 2
- Placebo
- Linagliptin 5mg
-
Birmingham, Alabama
- +73 more
Jan 13, 2017
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec
-
Birmingham, Alabama
- +44 more
Jan 20, 2017